Royce Micro-Cap Trust Inc Aktie News

NEW YORK, 1. Sept. 2026 /PRNewswire/ -- Royce Micro-Cap Trust, Inc. (NYSE-RMT) hat eine quartalsweise Ausschüttung von $0,23 je Aktie auf seine Stammaktien erklärt.

Durchschnittliches wöchentliches Handelsvolumen von etwa 674.921 Aktien Anlageberater des Fonds verfügt über mehr als 50 Jahre Erfahrung im Small- und Micro-Cap-Investment NEW YORK, 25. Aug. 2026 /PRNewswire/ -- SCHLUSSKURSE STAND 31.07.26 NAV 15,30 MKT 13,62 DURCHSCHNITTLICHE JÄHRLICHE GESAMTRÜCKKEHR STAND 31.07.26 NAV (%) MKT (%) Ein Monat* -8,66 -6,97 Jahr bis heute* 33,96 34,80 Ein Jahr 52,...

Durchschnittliches wöchentliches Handelsvolumen von ungefähr 735.990 Aktien Fondsberater hat mehr als 50 Jahre Erfahrung im Small- und Micro-Cap-Investing NEW YORK, 23. Juli 2026 /PRNewswire/ -- SCHLUSSKURSE STAND 30.06.26 NAV 16,75 MKT 14,64 DURCHSCHNITTLICHE JÄHRLICHE GESAMTRÜCKKEHREN STAND 30.06.26 NAV (%) MKT (%) Ein-Monats* 8,06 5,81 Jahr bis Datum* 46,65 44,89 Ein-Jahr 70,39 70,02 Drei-Ja...

NEW YORK, June 24, 2026 /PRNewswire/ --  Average weekly trading volume of approximately 531,385 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 05/31/26 NAV 15.73 MKT 14.04 AVERAGE ANNUAL TOTAL RETURN AS OF 05/31/26 NAV (%) MKT (%) One-Month* 6.21 6.20 Year to Date* 35.72 36.93 One-Year 70.80 73.35 Three-Year 28.50 29.82 Five-Year ...

Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy  Development programme complements Company's autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient populati...

NEW YORK, June 1, 2026 /PRNewswire/ -- Royce Micro-Cap Trust, Inc. (NYSE-RMT) has declared a quarterly distribution of $0.21 per share on its Common Stock. The distribution, optionally payable in additional shares of Common Stock, or in cash by specific stockholder election, is to be paid on June 29, 2026, to stockholders of record at the close of business on June 11, 2026 (ex-dividend on June ...

NEW YORK, May 20, 2026 /PRNewswire/ -- Average weekly trading volume of approximately 641,137 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING PRICES AS OF 04/30/26 NAV 14.81 MKT 13.22 AVERAGE ANNUAL TOTAL RETURN AS OF 04/30/26 NAV (%) MKT (%) One-Month* 15.88 16.89 Year to Date* 27.78 28.93 One-Year 72.98 74.60 Three-Year 26.07 26.78 Five-Year ...

RTX001 is an engineered Regenerative Macrophage Therapy for end-stage liver disease (ESLD) with anti-inflammatory and anti-fibrotic properties These new preclinical data demonstrate RTX001's pharmacology, safety, tolerability, and efficacy in mouse models, with reduced fibrosis and inflammation observed Results confirm RTX001's positive preclinical safety and therapeutic profile ahead of interi...